Ken Griffin Harvard Bioscience Inc Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.64 - $3.54 $2,376 - $3,186
900 Added 75.0%
2,100 $5,000
Q2 2024

Aug 14, 2024
SELL
$2.77 - $4.63 $2,770 - $4,630
-1,000 Reduced 45.45%
1,200 $3,000
Q1 2024

May 15, 2024
BUY
$4.02 - $5.39 $8,843 - $11,858
2,200 New
2,200 $9,000
Q3 2023

Nov 14, 2023
BUY
$4.0 - $5.82 $4,800 - $6,984
1,200 Added 600.0%
1,400 $6,000
Q2 2023

Aug 14, 2023
SELL
$4.19 - $6.16 $838 - $1,232
-200 Reduced 50.0%
200 $1,000
Q1 2023

May 15, 2023
BUY
$2.45 - $4.22 $980 - $1,688
400 New
400 $1,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email